Teva Pharmaceuticals Usa, Inc. Supplemental Unemployment Benefit Plan — Form 5500 plan (Teva Pharmaceuticals Usa, Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Teva Pharmaceuticals Usa, Inc. Supplemental Unemployment Benefit Plan is a benefit plan reported by Teva Pharmaceuticals Usa, Inc. under EIN 22-1734359 and plan number 510. The latest loaded filing year is 2023. The filing reports 5,181 participants and $791 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Teva Pharmaceuticals Usa, Inc.
EIN
22-1734359
Plan number
510
Plan type
2
Location
Parsippany, NJ
Latest filing year
2023
Participants
5,181
End-of-year plan assets
$791

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
20235,181H, C20241008101829NAL0017394433001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$791
Total liabilities (EOY)
$0
Net assets (EOY)
$791
Net assets (BOY)
$6,051

Income & contributions

Employer contributions
$4,572,772
Total contributions
$4,572,772
Total income / additions
$4,574,012

Expenses & distributions

Benefits paid
$4,574,272
Administrative expenses
$5,000
Total expenses
$4,579,272
Net increase / (decrease)
-$5,260

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Bank Of America, NaNONE$5,000not reported in the loaded dataset2023

Related Form 5500 pages